CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Beijing Beilu Pharmaceutical Company Limited Company Snapshot
Beijing Beilu Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Beijing Beilu Pharmaceutical Company Limited with three other companies in this sector in China: Lanzhou Foci Pharmaceutical Co Limited (2017 sales of 501.14 million Chinese Renmimbi [US$78.50 million] of which 100% was Pharmacies), Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (497.69 million Chinese Renmimbi [US$77.96 million] ), and Coland Holdings Limited (586.59 million Chinese Renmimbi [US$91.88 million] of which 100% was Medical Services).

Sales Analysis. Beijing Beilu Pharmaceutical Company Limited reported sales of 522.54 million Chinese Renmimbi (US$81.85 million) for the year ending December of 2017. This represents an increase of 4.8% versus 2016, when the company's sales were 498.81 million Chinese Renmimbi. Sales at Beijing Beilu Pharmaceutical Company Limited have increased during each of the previous five years (and since 2012, sales have increased a total of 92%). Sales of Pharmaceutical Sales saw an increase that was more than double the company's growth rate: sales were up 10.6% in 2017, from 469.91 million Chinese Renmimbi to 519.81 million Chinese Renmimbi. Not all segments of Beijing Beilu Pharmaceutical Company Limited experienced an increase in sales in 2017: sales of Other Operation fell 42.7% to 2.72 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Beijing Beilu Pharmaceutical Company Limited
  Stock Performance Chart for Beijing Beilu Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (5/18/2018): 15.48
(Figures in Chinese Renmimbi)
1 Week 9.6%   13 Weeks n/a  
4 Weeks 37.1%   52 Weeks 4.4%  
 
Beijing Beilu Pharmaceutical Company Limited Key Data:
  Ticker: 300016 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 522,538,130
(Year Ending Jan 2018).
Employees: 461
  Currency: Chinese Renmimbi Market Cap: 5,046,375,525
  Fiscal Yr Ends: December Shares Outstanding: 325,993,251
  Share Type: A Gu Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.